List of Excipients in API tranylcypromine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tranylcypromine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | ANHYDROUS CITRIC ACID | |
Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CARNAUBA WAX | |
Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CELLULOSE, MICROCRYSTALLINE | |
Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CROSCARMELLOSE SODIUM | |
Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | D&C RED NO. 7 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tranylcypromine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 | CARMINIC ACID |
Lannett Company Inc | tranylcypromine | 0527-3010 | CELLULOSE, MICROCRYSTALLINE |
Lannett Company Inc | tranylcypromine | 0527-3010 | FD&C RED NO. 40 |
Lannett Company Inc | tranylcypromine | 0527-3010 | MAGNESIUM PALMITOSTEARATE |
Lannett Company Inc | tranylcypromine | 0527-3010 | POLYETHYLENE GLYCOL 3350 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for tranylcypromine
Excipient focus: ANHYDROUS CITRIC ACID
tranylcypromine drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SULFATE
tranylcypromine drug variants containing CALCIUM SULFATE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CALCIUM SULFATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SULFATE DIHYDRATE
tranylcypromine drug variants containing CALCIUM SULFATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CALCIUM SULFATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
tranylcypromine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CARMINIC ACID
tranylcypromine drug variants containing CARMINIC ACID
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARMINIC ACID
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
tranylcypromine drug variants containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tranylcypromine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
tranylcypromine drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
tranylcypromine drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
tranylcypromine drug variants containing D&C RED NO. 7
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing D&C RED NO. 7
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
tranylcypromine drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
tranylcypromine drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
tranylcypromine drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
tranylcypromine drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: GELATIN
tranylcypromine drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
tranylcypromine drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
tranylcypromine drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
tranylcypromine drug variants containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM PALMITOSTEARATE
tranylcypromine drug variants containing MAGNESIUM PALMITOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing MAGNESIUM PALMITOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
tranylcypromine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tranylcypromine drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 3350
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tranylcypromine drug variants containing POLYVINYL ALCOHOL
tranylcypromine drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
tranylcypromine drug variants containing SILICON DIOXIDE
tranylcypromine drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
tranylcypromine drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Alvogen Inc | tranylcypromine sulfate | 47781-517 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing STARCH, CORN
Excipient focus: TALC
tranylcypromine drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tranylcypromine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | tranylcypromine | 0527-3010 |
Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
Solco Healthcare US LLC | tranylcypromine | 43547-655 |
Novitium Pharma LLC | tranylcypromine | 70954-538 |
Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
>Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.